FDA.reportPublic FDA data

Bcl-2 oncoprotein IVD, control

Definition
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of Bcl-2 oncoprotein in a clinical specimen.
GUDID devices
5
Last updated
2025-03-26 08:21:29

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
B502BSB9029CS0bcl-2 Control SlidesBIO SB, INC.BSB-9029-CS2025-03-18
B502BSB50770bcl-2 control slidesBIO SB, INC.Control Slides, 52020-06-01
B502BSB65440bcl-2 RMabBIO SB, INC.Concentrate, 0.1 ml2020-03-16
B502BSB65470bcl-2 control slidesBIO SB, INC.Control Slides, 52020-06-01
L502BSB6544bcl-2 RMabBIO SB, INC.Concentrate, 0.1 ml2020-03-16